COVID‐19, cancer post‐pandemic risk, and the radiation oncology physicist

Allen, Mary Beth

doi:10.1002/acm2.13628

Cited by 3 publications

(2 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…During the COVID crisis, nearly every aspect of healthcare organization was affected, including research and development, human resource management, healthcare delivery, and conduct of clinical trials [ 1 , 2 ]. A major worry during this time was to protect the continuity of care of chronic disease patients.…”

Section: Introductionmentioning

confidence: 99%

What went right during the COVID crisis: The capabilities of local actors and lasting innovations in oncology care and research

Bogaert,

Kozlakidis,

Caboux

et al. 2023

PLOS Glob Public Health

View full text Add to dashboard Cite

This article will elaborate how oncology care and research was adapted during the COVID pandemic in the Metropole of Lyon (France), including the lasting innovations that came out of the crisis. The research method involved 22 semi-structured qualitative interviews of healthcare professionals, managers, and researchers in the Lyon, France region coming from both public and private academic hospitals. The interviews took place from February 2021-December 2022 in order to assess the long-term adaptations and innovations in cancer care organization in the post-COVID era. The main results show adaptations and innovations in 1) new processes and resources to facilitate disciplinary and interdisciplinary work; 2) harmonization and streamlining of patient journeys. In the discussion section, we will mobilize the capabilities approach, an interdisciplinary social sciences approach that focuses on the capabilities of persons to be and to do, to elaborate the conditions by which local actors were able to be agile, to adapt and to innovate in spite of the healthcare emergency and in coherence with their professional and personal values.

show abstract

Section: Introductionmentioning

confidence: 99%

What went right during the COVID crisis: The capabilities of local actors and lasting innovations in oncology care and research

Bogaert,

Kozlakidis,

Caboux

et al. 2023

PLOS Glob Public Health

View full text Add to dashboard Cite

show abstract

“…Potential biases should be also considered. Perhaps most importantly, the COVID-19 pandemic has been associated with a sharp decline in cancer screening [ 117 , 118 ]. So, a national population-based modelling study that analysed the impact of COVID-19 pandemic on cancer delays and survival suggested that significant increases in the number of avoidable cancer deaths could be expected as a result of diagnostic delays [ 118 ].…”

Section: Limitations and Perspectivesmentioning

confidence: 99%

Should We Expect an Increase in the Number of Cancer Cases in People with Long COVID?

et al. 2023

View full text Add to dashboard Cite

The relationship between viral infections and the risk of developing cancer is well known. Multiple mechanisms participate in and determine this process. The COVID-19 pandemic caused by the SARS-CoV-2 virus has resulted in the deaths of millions of people worldwide. Although the effects of COVID-19 are limited for most people, a large number of people continue to show symptoms for a long period of time (long COVID). Several studies have suggested that cancer could also be a potential long-term complication of the virus; however, the causes of this risk are not yet well understood. In this review, we investigated arguments that could support or reject this possibility.

show abstract